A prospective randomized study comparing supraglottic airway device-guided endotracheal intubation using Ambu Aura40 versus Ambu Aura-i
Journal of Emergency Medicine, Trauma & Acute Care · 2026 · 2026 (2)
DOI: 10.5339/jemtac.2026.29 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Emergency Medicine, Trauma & Acute Care, 2026. Verfasst von Sumedha Vashishth und 5 weiteren Autor:innen. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Supraglottic airway devices (SADs) play a pivotal role in managing both routine and difficult airways and can serve as conduits for blind or fiberoptic-guided endotracheal intubation. This study compared two different SADs, the Ambu Aura-i and the Ambu Aura40, which have not been previously compared in the literature. Methodology: This prospective randomized study was conducted at a tertiary care center from June 2023 to May 2024 and enrolled 60 patients aged 18–60 years who were scheduled for elective surgery under general anesthesia. Patients were randomized into two groups: Group A (n=30), in which Ambu Aura40 was used, and Group B ( n = 30), in which Ambu Aura-i was used. After SAD placement, a lubricated endotracheal tube (ETT) was advanced through the device. Outcome measures included insertion time, ease of placement, number of attempts, and failure rate. Data was analyzed using SPSS version 22.0.
Results
Ambu Aura-i group had a considerably shorter insertion time than the Ambu Aura 40 group (17.46 ± 13.93 vs. 30.25 ± 17.31 s; p = 0.01) and a lower failure rate [5 (16.7%) patients vs. 14 (46.7%) patients; p=0.01]. ETT placement was easier in the Ambu Aura-i group compared with the Ambu Aura40 group [19 (63.3%) patients vs. 9 (30%) patients; p=0.003). ETT placement through SAD was successful in the first attempt in 8 (26.7%) patients in Group A and 17 (56.7%) patients in Group B.
Conclusion
Both airway devices were suitable for ventilation and oxygenation; however, the Ambu Aura-i had a higher success rate in facilitating tracheal intubation than the Ambu Aura40.
Zitieren
APA
Vashishth, S., Yadav, N., Kumar, P., Kaur, K., Bangarwa, N., & Anshul (2026). A prospective randomized study comparing supraglottic airway device-guided endotracheal intubation using Ambu Aura40 versus Ambu Aura-i. Journal of Emergency Medicine, Trauma & Acute Care, 2026(2). https://doi.org/10.5339/jemtac.2026.29
Vancouver
Vashishth S, Yadav N, Kumar P, Kaur K, Bangarwa N, Anshul. A prospective randomized study comparing supraglottic airway device-guided endotracheal intubation using Ambu Aura40 versus Ambu Aura-i. Journal of Emergency Medicine, Trauma & Acute Care. 2026;2026(2). doi:10.5339/jemtac.2026.29
BibTeX
@article{Vashishth2026,
author = {Vashishth, Sumedha and Yadav, Nisha and Kumar, Prashant and Kaur, Kiranpreet and Bangarwa, Nidhi and Anshul},
title = {A prospective randomized study comparing supraglottic airway device-guided endotracheal intubation using Ambu Aura40 versus Ambu Aura-i},
journal = {Journal of Emergency Medicine, Trauma & Acute Care},
year = {2026},
volume = {2026},
number = {2},
doi = {10.5339/jemtac.2026.29}
}
EUVIMED